Company Profile
ConjuGon was founded in 2001 by University of Wisconsin-Madison professors Marcin Filutowicz and Richard Burgess to develop products to combat the growing epidemic of antibiotic resistance. Today, the company has a dedicated team working on products to prevent and treat bacterial infections.
The company's lead product, C-1205, is used to prevent catheter-associated urinary tract infections. This technology was licensed from the Baylor College of Medicine in Houston.
The company's second product, B-4474, is used to treat wound infections. This product is based on technology invented by Dr. Filutowicz.
ConjuGon continues to advance these products with the goal of one day helping patients prevent and treat these killer infections.
